Literature DB >> 31413065

Trends in Disparities in Preemptive Kidney Transplantation in the United States.

Kristen L King1,2, Syed Ali Husain1,2, Zhezhen Jin3, Corey Brennan2, Sumit Mohan4,2,5.   

Abstract

BACKGROUND AND OBJECTIVES: Long wait times for deceased donor kidneys and low rates of preemptive wait-listing have limited preemptive transplantation in the United States. We aimed to assess trends in preemptive deceased donor transplantation with the introduction of the new Kidney Allocation System (KAS) in 2014 and identify whether key disparities in preemptive transplantation have changed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified adult deceased donor kidney transplant recipients in the United States from 2000 to 2018 using the Scientific Registry of Transplant Recipients. Preemptive transplantation was defined as no dialysis before transplant. Associations between recipient, donor, transplant, and policy era characteristics and preemptive transplantation were calculated using logistic regression. To test for modification by KAS policy era, an interaction term between policy era and each characteristic of interest was introduced in bivariate and adjusted models.
RESULTS: The proportion of preemptive transplants increased after implementation of KAS from 9.0% to 9.8%, with 1.10 (95% confidence interval [95% CI], 1.06 to 1.14) times higher odds of preemptive transplantation post-KAS compared with pre-KAS. Preemptive recipients were more likely to be white, older, female, more educated, hold private insurance, and have ESKD cause other than diabetes or hypertension. Policy era significantly modified the association between preemptive transplantation and race, age, insurance status, and Human Leukocyte Antigen zero-mismatch (interaction P<0.05). Medicare patients had a significantly lower odds of preemptive transplantation relative to private insurance holders (pre-KAS adjusted OR, [aOR] 0.26; [95% CI, 0.25 to 0.27], to 0.20 [95% CI, 0.18 to 0.22] post-KAS). Black and Hispanic patients experienced a similar phenomenon (aOR 0.48 [95% CI, 0.45 to 0.51] to 0.41 [95% CI, 0.37 to 0.45] and 0.43 [95% CI, 0.40 to 0.47] to 0.40 [95% CI, 0.36 to 0.46] respectively) compared with white patients.
CONCLUSIONS: Although the proportion of deceased donor kidney transplants performed preemptively increased slightly after KAS, disparities in preemptive kidney transplantation persisted after the 2014 KAS policy changes and were exacerbated for racial minorities and Medicare patients.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  European Continental Ancestry Group; HLA antigens; Hispanic Americans; Insurance Coverage; Medicare; Registries; United States; adult; allocation system; chronic kidney failure; deceased donor; diabetes mellitus; female; health policy; humans; hypertension; kidney failure, chronic; kidney transplantation; logistic models; preemptive kidney transplantation; renal dialysis; tissue donors; transplant recipients; unintended consequences

Mesh:

Year:  2019        PMID: 31413065      PMCID: PMC6777592          DOI: 10.2215/CJN.03140319

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  28 in total

1.  Preemptive renal transplant candidate survival, access to care, and renal function at listing.

Authors:  Rachel B Fissell; Titte Srinivas; Rich Fatica; Joseph Nally; Sankar Navaneethan; Emilio Poggio; David Goldfarb; Jesse Schold
Journal:  Nephrol Dial Transplant       Date:  2012-03-15       Impact factor: 5.992

2.  Association between Medicaid Expansion under the Affordable Care Act and Preemptive Listings for Kidney Transplantation.

Authors:  Meera N Harhay; Ryan M McKenna; Suzanne M Boyle; Karthik Ranganna; Lissa Levin Mizrahi; Stephen Guy; Gregory E Malat; Gary Xiao; David J Reich; Michael O Harhay
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-21       Impact factor: 8.237

Review 3.  The kidney-first initiative: what is the current status of preemptive transplantation?

Authors:  John J Friedewald; Peter P Reese
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

4.  Opportunities for Increasing the Rate of Preemptive Kidney Transplantation.

Authors:  Steven Fishbane; Vinay Nair
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-16       Impact factor: 8.237

5.  Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis.

Authors:  Herwig-Ulf Meier-Kriesche; Bruce Kaplan
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

6.  Impact of race on predialysis discussions and kidney transplant preemptive wait-listing.

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Kirsten L Johansen
Journal:  Am J Nephrol       Date:  2012-03-09       Impact factor: 3.754

Review 7.  Preemptive transplantation and the transplant first initiative.

Authors:  Connie L Davis
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-11       Impact factor: 2.894

8.  Preemptive kidney transplantation: the advantage and the advantaged.

Authors:  Bertram L Kasiske; Jon J Snyder; Arthur J Matas; Mary D Ellison; John S Gill; Annamaria T Kausz
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

9.  Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.

Authors:  Chi-Yuan Hsu; Feng Lin; Eric Vittinghoff; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

10.  Preemptive deceased donor kidney transplantation: considerations of equity and utility.

Authors:  Morgan E Grams; B Po-Han Chen; Josef Coresh; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

View more
  24 in total

1.  Persistent Disparities in Preemptive Kidney Transplantation.

Authors:  Tanjala S Purnell; Deidra C Crews
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-26       Impact factor: 8.237

2.  Will Universal Access to Health Care Mean Equitable Access to Kidney Transplantation?

Authors:  Meera N Harhay; Patrick B Mark
Journal:  Clin J Am Soc Nephrol       Date:  2020-05-28       Impact factor: 8.237

3.  Modest rates and wide variation in timely access to repeat kidney transplantation in the United States.

Authors:  Jesse D Schold; Joshua J Augustine; Anne M Huml; John O'Toole; John R Sedor; Emilio D Poggio
Journal:  Am J Transplant       Date:  2019-11-15       Impact factor: 8.086

4.  Disparities in Access to Preemptive Repeat Kidney Transplant: Still Missing the Mark?

Authors:  Amanda J Vinson; Bryce A Kiberd; Kenneth West; Roslyn B Mannon; Bethany J Foster; Karthik K Tennankore
Journal:  Kidney360       Date:  2021-10-20

5.  A Second Chance at Transplant First: Preemptive Repeat Kidney Transplantation.

Authors:  Anne M Huml; Jesse D Schold
Journal:  Kidney360       Date:  2022-01-27

6.  Disparities in Discussions about Kidney Replacement Therapy in CKD Care.

Authors:  Tyler M Barrett; Clemontina A Davenport; Patti L Ephraim; Sarah Peskoe; Dinushika Mohottige; Nicole DePasquale; Lisa McElroy; L Ebony Boulware
Journal:  Kidney360       Date:  2021-10-22

7.  Pretransplant Dialysis and Preemptive Transplant in Living Donor Kidney Recipients.

Authors:  Mason Lai; Ying Gao; Mehdi Tavakol; Chris Freise; Brian K Lee; Meyeon Park
Journal:  Kidney360       Date:  2022-04-18

8.  Failure to Advance Access to Kidney Transplantation over Two Decades in the United States.

Authors:  Jesse D Schold; Sumit Mohan; Anne Huml; Laura D Buccini; John R Sedor; Joshua J Augustine; Emilio D Poggio
Journal:  J Am Soc Nephrol       Date:  2021-02-11       Impact factor: 10.121

Review 9.  Managing Patients with Failing Kidney Allograft: Many Questions Remain.

Authors:  Scott Davis; Sumit Mohan
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-10       Impact factor: 8.237

Review 10.  Using race in the estimation of glomerular filtration rates: time for a reversal?

Authors:  Heather Morris; Sumit Mohan
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-03       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.